Literature DB >> 17571526

Treatment completion among TB patients returned to the community from a large urban jail.

Seijeoung Kim1, Kathleen Crittenden.   

Abstract

Despite the current decline of TB in the general population, the prevalence of TB remains conspicuously higher among inmates. While treatment completion is a key to controlling and preventing drug-resistant TB, it is difficult to be achieved among incarcerated populations due to their social, economic, and behavioral characteristics. This article examined factors associated with treatment completion among jail inmates with TB disease after their return to the community. Retrospective analyses were performed to explore the relationships between demographic, behavioral, incarceration factors, and treatment methods with treatment completion. Hispanics (vs. blacks), those who had children, and those incarcerated for simple charges (vs. drug related charges) were less likely to complete treatment. DOT users were more likely to complete treatment then those who used the self administration method. Inmates whose DOT was administered at a field site were more likely to complete treatment than those whose DOT took place at a clinic or mixed clinic and field. Although mixed DOT might be less expensive than field DOT, it represented no significant improvement over clinic DOT. Treatment methods must employ an outreach strategy to meet each patient's need, considering the broader socioeconomic context.

Entities:  

Mesh:

Year:  2007        PMID: 17571526     DOI: 10.1007/s10900-006-9036-2

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  28 in total

1.  Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).

Authors:  H G Tangüis; J A Caylà; P G García de Olalla; J M Jansà; M T Brugal
Journal:  Int J Tuberc Lung Dis       Date:  2000-01       Impact factor: 2.373

2.  Eleven years of community-based directly observed therapy for tuberculosis.

Authors:  C P Chaulk; K Moore-Rice; R Rizzo; R E Chaisson
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

3.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

4.  "Culturalizing" the upsurge of tuberculosis.

Authors:  F Barnhoorn; S van der Geest
Journal:  Soc Sci Med       Date:  1997-11       Impact factor: 4.634

5.  Resource implications of patients with multidrug resistant tuberculosis.

Authors:  V L White; J Moore-Gillon
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

6.  Incidence of TB in inmates with latent TB infection: 5-year follow-up.

Authors:  Mary C White; Jacqueline P Tulsky; Enrique Menendez; Joe Goldenson; L Masae Kawamura
Journal:  Am J Prev Med       Date:  2005-11       Impact factor: 5.043

7.  HIV prevalence and risk behaviors among patients attending Los Angeles County Tuberculosis Clinics: 1993-1996.

Authors:  J López; H Welvaart; W Ford; P Kerndt
Journal:  Ann Epidemiol       Date:  1998-04       Impact factor: 3.797

8.  The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis.

Authors:  S J Heymann; R Sell; T F Brewer
Journal:  Am J Public Health       Date:  1998-03       Impact factor: 9.308

9.  Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.

Authors:  B Lebouché; Y Yazdanpanah; Y Gérard; D Sissoko; F Ajana; I Alcaraz; P Boitte; B Cadoré; Y Mouton
Journal:  HIV Med       Date:  2006-04       Impact factor: 3.180

10.  Tuberculosis in undocumented migrants, Geneva.

Authors:  Sigiriya Aebischer Perone; Patrick Bovier; Christian Pichonnaz; Thierry Rochat; Louis Loutan
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  1 in total

1.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.